By Adriano Marchese
Medicenna Therapeutics has appointed Jeff Caravella as its new chief financial officer.
Caravella brings with him over two decades of global healthcare, financial and operational experience to the clinical-stage immunotherapy company, Medicenna said Monday.
Most recently, he served as CFO at biopharmaceutical company Biotheryx, and before that, as vice president of finance at Tango Therapeutics.
Medicenna said that the appointment comes at a time when it is focusing on establishing a presence in Boston.
Write to Adriano Marchese at adriano.marchese@wsj.com
Read the full article here